BlackRock Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.63M | Sell |
78,719
-231
| -0.3% | -$4.78K | ﹤0.01% | 2365 |
|
|
2016
Q3 | $1.28M | Buy |
78,950
+637
| +0.8% | +$10.3K | ﹤0.01% | 2486 |
|
|
2016
Q2 | $1.07M | Buy |
78,313
+13,143
| +20% | +$179K | ﹤0.01% | 2575 |
|
|
2016
Q1 | $1.14M | Buy |
65,170
+1,394
| +2% | +$24.3K | ﹤0.01% | 2393 |
|
|
2015
Q4 | $2.18M | Buy |
63,776
+8,484
| +15% | +$290K | ﹤0.01% | 2012 |
|
|
2015
Q3 | $1.65M | Sell |
55,292
-376
| -0.7% | -$11.2K | ﹤0.01% | 2220 |
|
|
2015
Q2 | $1.78M | Buy |
55,668
+28,727
| +107% | +$919K | ﹤0.01% | 2331 |
|
|
2015
Q1 | $558K | Buy |
26,941
+405
| +2% | +$8.39K | ﹤0.01% | 2897 |
|
|
2014
Q4 | $450K | Buy |
26,536
+222
| +0.8% | +$3.77K | ﹤0.01% | 3052 |
|
|
2014
Q3 | $509K | Buy |
26,314
+4,831
| +22% | +$93.4K | ﹤0.01% | 2950 |
|
|
2014
Q2 | $730K | Buy |
21,483
+2,283
| +12% | +$77.6K | ﹤0.01% | 2812 |
|
|
2014
Q1 | $605K | Buy |
+19,200
| New | +$605K | ﹤0.01% | 2827 |
|